TRAX Insider Trading Activity and SEC Form 4 Filings
TRAX insider trading summary
Over the past 12 months, insiders at First Tracks Biotherapeutics, Inc. (TRAX) reported 2 sales worth $66.8M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $66.8M.
Latest TRAX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 2, 2026 | J. Anthony Ware | Insider | Sell | $1.8M (39,265 @ $44.78) |
| Apr 20, 2026 | EcoR1 Capital, LLC | 10% Owner | Sell | $65.0M (4,705,575 @ $13.81) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.